Drug Device Combination Market Research Report – Global Forecast till 2023

Drug Device Combination Market research report, by Product (catheter, antimicrobial applications, advanced wound care products), Application (coronary angioplasty, tachycardia management), End user (hospitals & clinics) – Global Forecast till 2023 

ID: MRFR/MED/5481-HCR | February 2021 | Region: Global | 90 pages

Market Scenario:


Global Drug Device Combination is expected to register a CAGR of 11.4% during the forecast period of 2018 to 2023.


 In this market, products that comprises of more than two regulated components, i.e., drug and device are considered. Such devices are extensively utilized for therapeutic purposes against diseases like cardiovascular diseases. From the past few years, the global burden of the diseases like cardiovascular diseases, urology diseases, and others have increased.  This provided suitable backgrounds for the market to develop and grow. According to the factsheet of 2017 published by the Centers for Disease Control and Prevention it was estimated that ~610,000 people within the U.S. die from heart diseases. Moreover, it is mentionable that from the past few years, the reported cases of urology diseases have increased. According to the cancer research UK, there were ~47,151 new cases of prostate cancer within the region. This is estimated to significantly increase the demand for drug devices for the related therapeutics, enabling the drug device combination market to grow.


Additionally, factors such as growing healthcare expenditure, rising awareness for the disease, and increasing R&D expenses by the key players drives the global drug device combination market. However, side effects, high cost of the products, and presence of low income countries within the developing regions restricts the market growth. It has been reported that products like Cypher causes thrombosis. 


Segmentation:


The Global Drug Device Combination is segmented based on product, application, end user and region.Based on product, the market is segmented into catheter, advanced wound care products, and others. The catheter segment is sub-segmented into antimicrobial catheter, urological catheters, cardiovascular catheters, oximetry catheters, thermodilution catheters, wound drainage catheter, and others. The advanced wound care products segment is sub-divided into antibiotic wound care, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy. The bone graft substitutes segment is sub-segmented into ceramic based bone graft substitute, allograft-based bone graft substitutes, cell-based bone graft substitutes, and others. On the basis of application, the market is devised into coronary angioplasty, tachycardia management, non-cardiovascular treatments, peripheral arterial disease (pad), bone treatment, antimicrobial applications, wound care, ophthalmic treatment, and others. By end user, the market is divided into hospitals & clinics, ambulatory centres, and academic & research organization, and others. In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely- the Americas, Europe, Asia-Pacific and the Middle East & African region.


Regional Market Summary


Global Drug Device Combination Share (%), by Region, 2017


Sources:


The Americas dominated the Global Market for Drug Device Combination products owing to rising prevalence of cardiovascular diseases and presence of major market players within the region. Additionally, suitable reimbursement policies, high healthcare expenditure, and developed healthcare sector in the U.S. and Canada boost the market to grow. In 2017, it was estimated that Europe stood second in the global drug device combination owing to the to the presence of a well-developed healthcare infrastructure, increasing awareness for the devices within the region and presence of developed economies within the region. Additionally, a large patient pool boosts the market.


Asia Pacific was projected to be the fastest growing region in 2017. This can be attributed due to the increasing penetration of the market players within the region, growing healthcare sector and increasing government support for foreign investments. According to a report published by the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to grow at a CAGR of 22.87 and reach USD 280 billion by 2020.


On the other hand, the Middle East and Africa held least share in the Global Drug Device Combination Market due to the presence of poor economies and low per capita income, especially within the African region. The Middle Eastern region is estimated to be a major market for the Middle East and African region. This can be attributed due to increasing government funding in the healthcare followed by the presence of developed economies like United Arab Emirates, Saudi Arabia, Dubai, and others within the regional boundaries of the region. 


Key players: 


Some of the key players in the global drug device combination are 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics, Inc., Biometrix Medical, Biotronik, Boston Scientific Corporation, C.R. BARD, Inc., Cook Critical Care, Inc., Covidien Ltd, Smith & Nephew Plc, St. Jude Medical Inc, Stryker Corporation, Wright Medical Group, Inc., Zimmer Holding, Inc., and others.


Research Methodology: 


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  •         Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  •         Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the drug device combination. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience:



  • Pharmaceutical companies

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players


Global Drug Device Combination Market, by Product:



  •  Catheter

    • Antimicrobial catheter

    • Urological catheters

    • Cardiovascular catheters

    • Oximetry catheters

    • Thermodilution catheters

    • Wound drainage catheter

    • Others





  • Advanced Wound Care Products

    • Antibiotic wound care

    • Bone Graft Substitutes

      •    Ceramic based bone graft substitute

      •    Allograft based bone graft substitutes

      •   Cell based bone graft substitutes

      •   Others



    • Antibiotic Bone Cements

    • Drug Eluting Stents

    • Photodynamic Therapy

    • Others




Global Drug Device Combination Market, by Application:



  • Coronary angioplasty

  • Tachycardia management

  • Non-Cardiovascular Treatments

  • Peripheral arterial disease (PAD)

  • Bone Treatment

  • Antimicrobial Applications

  • Wound Care

  • Ophthalmic Treatment

  • Others


Global Drug Device Combination Market, by End User



  • Hospitals & Clinics

  • Ambulatory Centres

  • Academic & Research Organization


 


 


 


 



Frequently Asked Questions (FAQ) :


Drug Device Combination Market has a growth opportunity with an 11.4% CAGR during the forecast period of 2018 to 2023.

Americas would dominate the global Drug Device Combination Market.

Asia Pacific regional Drug Device Combination Market would be the fastest-growing among all the regions.

Drug Device Combination Market has players like AlloSource, 3M, Abbott Laboratories, Biometrix Medical, Biotronik, C.R. BARD, Boston Scientific Corporation, Biomet Orthopedics, Inc., Inc., Covidien Ltd, Cook Critical Care, Inc., St. Jude Medical Inc, Smith & Nephew Plc, Zimmer Holding, Inc., Stryker Corporation, Wright Medical Group, Inc., and others.

Drug Device Combination Market would be triggered by end users like academic & research organizations, ambulatory centers, hospitals & clinics, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Drug Device Combination Market, by Product

6.1 Introduction

6.2 Catheter

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.1 Antimicrobial catheter

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Urological catheters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.3 Cardiovascular catheters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.4 Oximetry catheters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
6.2.5 Thermodilution catheters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.6 Wound drainage catheter

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.7 Others

6.3 Advanced Wound Care Products

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1 Antibiotic wound care

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2 Bone Graft Substitutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2.1 Ceramic based bone graft substitute

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
6.3.2.2 Allograft based bone graft substitutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2.3 Cell based bone graft substitutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2.4 others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3 Antibiotic Bone Cements

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.4 Drug Eluting Stents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.5 Photodynamic Therapy

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.6 Others

Chapter 7. Global Drug Device Combination Market, by Application

7.1 Introduction

7.2 Coronary angioplasty

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.1 Tachycardia management

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.2 Non-Cardiovascular Treatments

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.3 Peripheral arterial disease (PAD)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Bone Treatment

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Antimicrobial Applications

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Wound Care

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.6 Ophthalmic Treatment

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.7 Other

Chapter 8. Global Drug Device Combination Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Ambulatory Centres

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Academic & Research Organization

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Drug Device Combination Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 3M

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Abbott Laboratories

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 AlloSource

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Biomet Orthopedics, Inc.

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Biometrix Medical

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Biotronik

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Boston Scientific Corporation

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 C.R. BARD, Inc.

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Cook Critical Care, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Covidien Ltd

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Smith & Nephew Plc

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 St. Jude Medical Inc

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Stryker Corporation

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Wright Medical Group, Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Zimmer Holding, Inc.

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 OtherS

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Drug Device Combination Market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Drug Device Combination Market Synopsis, 2018–2023

Table 2 Global Drug Device Combination Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Drug Device Combination Market, by Region, 2018–2023 (USD Million)

Table 4 Global Drug Device Combination Market, by Product, 2018–2023 (USD Million)

Table 5 Global Drug Device Combination Market, by Application, 2018–2023 (USD Million)

Table 6 Global Drug Device Combination Market, End User, 2018–2023 (USD Million)

Table 7 North America: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 8 North America: Drug Device Combination, by Application, 2018–2023 (USD Million)

Table 9 North America: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 10 US: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 11 US: Drug Device Combination , by Application, 2018–2023 (USD Million)

Table 12 US: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 13 Canada: Drug Device Combination,by Product, 2018–2023 (USD Million)

Table 14 Canada: Drug Device Combination, by Application, 2018–2023 (USD Million)

Table 15 Canada: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 16 South America: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 17 South America: Drug Device Combination, by Application, 2018–2023 (USD Million)

Table 18 South America: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 19 Europe: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 20 Europe: Drug Device Combination, by Application, 2018–2023 (USD Million)

Table 21 Europe: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 22 Western Europe: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 23 Western Europe: Drug Device Combination, by Application, 2018–2023 (USD Million)

Table 24 Western Europe: Drug Device Combination, by End User, 2018–2023 (USD Million)

Table 25 Eastern Europe: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 26 Eastern Europe: Drug Device Combination , by Application, 2018–2023 (USD Million)

Table 27 Eastern Europe: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 28 Asia-Pacific: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 29 Asia-Pacific: Drug Device Combination , by Application, 2018–2023 (USD Million)

Table 30 Asia-Pacific: Drug Device Combination, End User, 2018–2023 (USD Million)

Table 31 Middle East & Africa: Drug Device Combination, by Product, 2018–2023 (USD Million)

Table 32 Middle East & Africa: Drug Device Combination , by Application, 2018–2023 (USD Million)

Table 33 Middle East & Africa: Drug Device Combination, End User, 2018–2023 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Drug Device Combination Market

Figure 3 Market Dynamics for Global Drug Device Combination Market

Figure 4 Global Drug Device Combination Market Share, by Product, 2017

Figure 5 Global Drug Device Combination Market Share, by Application, 2017

Figure 6 Global Drug Device Combination Market Share, End User, 2017

Figure 7 Global Drug Device Combination Market Share, by Region, 2017

Figure 8 North America: Drug Device Combination Market Share, by Country, 2017

Figure 9 Europe: Drug Device Combination MarketShare, by Country, 2017

Figure 10 Asia-Pacific: Drug Device Combination Market Share, by Country, 2017

Figure 11 Middle East & Africa: Drug Device Combination Market Share, by Region, 2017

Figure 12 Global Drug Device Combination Market: Company Share Analysis, 2017 (%)

Figure 13 3M: Key Financials

Figure 14 3M: Segmental Revenue

Figure 15 3M: Geographical Revenue

Figure 16 Abbott Laboratories: Key Financials

Figure 17 Abbott Laboratories: Segmental Revenue

Figure 18 Abbott Laboratories: Geographical Revenue

Figure 19 AlloSource: Key Financials

Figure 20 AlloSource: Segmental Revenue

Figure 21 AlloSource: Geographical Revenue

Figure 22 Biomet Orthopedics, Inc.: Key Financials

Figure 23 Biomet Orthopedics, Inc.: Segmental Revenue

Figure 24 Biomet Orthopedics, Inc.: Geographical Revenue

Figure 25 Biotronik: Key Financials

Figure 26 Biotronik: Segmental Revenue

Figure 27 Biotronik: Geographical Revenue

Figure 28 Boston Scientific Corporation: Key Financials

Figure 29 Boston Scientific Corporation: Segmental Revenue

Figure 30 Boston Scientific Corporation: Geographical Revenue

Figure 31 C.R. BARD, Inc.: Key Financials

Figure 32 C.R. BARD, Inc.: Segmental Revenue

Figure 33 C.R. BARD, Inc.: Geographical Revenue

Figure 34 Cook Critical Care, Inc.: Key Financials

Figure 35 Cook Critical Care, Inc.: Segmental Revenue

Figure 36 Cook Critical Care, Inc.: Geographical Revenue

Figure 37 Covidien Ltd: Key Financials

Figure 38 Covidien Ltd: Segmental Revenue

Figure 39 Covidien Ltd: Geographical Revenue

Figure 40 Smith & Nephew Plc: Key Financials

Figure 41 Smith & Nephew Plc: Segmental Revenue

Figure 42 Smith & Nephew Plc: Geographical Revenue

Figure 43 St. Jude Medical Inc: Key Financials

Figure 44 St. Jude Medical Inc: Segmental Revenue

Figure 45 St. Jude Medical Inc: Geographical Revenue

Figure 46 Stryker Corporation: Key Financials

Figure 47 Stryker Corporation: Segmental Revenue

Figure 48 Stryker Corporation: Geographical Revenue

Figure 49 Wright Medical Group, Inc.: Key Financials

Figure 50 Wright Medical Group, Inc.: Segmental Revenue

Figure 51 Wright Medical Group, Inc.: Geographical Revenue